; Whereas the PEPFAR program remains the largest commitment in history by any country to combat a single disease; Whereas, as of 2019, PEPFAR has supported treatment for approximately 15,700,000 people, including by providing antiretroviral drugs to 2,600,000 pregnant women living with HIV to prevent the transmission of HIV from mother to child during birth; Whereas, in fiscal year 2019, PEPFAR directly supported HIV testing and counseling for 79,600,000 people; Whereas the Global Fund to Fight AIDS, Tuberculosis and Malaria, launched in 2002, has helped provide antiretroviral therapy to approximately 20,100,000 people living with HIV/AIDS and to 718,000 pregnant women to prevent the transmission of HIV/AIDS to their children, saving an estimated 38,000,000 lives, as of 2019; Whereas the United States is the largest donor to the Global Fund to Fight AIDS, Tuberculosis and Malaria, and every $1 contributed by the United States leverages an additional $2 from other donors, as required by law; Whereas considerable progress has been made in the fight against HIV/AIDS, including a 23-percent reduction in new HIV transmissions, over a 40-percent reduction in new HIV transmissions among children, and over a 30-percent reduction in the number of AIDS-related deaths between 2010 and 2019; Whereas approximately 25,400,000 people had access to antiretroviral therapy in 2019, compared to only 7,800,000 people who had access to such therapy in 2010; Whereas research funded by the National Institutes of Health found that HIV treatment not only saves the lives of people living with HIV, but people living with HIV on effective antiretroviral therapy and who are durably virally suppressed cannot sexually transmit HIV, proving that HIV treatment is prevention; Whereas it is estimated that, without treatment, half of all infants living with HIV will die before their second birthday; Whereas despite the remarkable progress in combating HIV, significant challenges remain